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ABSTRACT 
Objective:  To determine the clinical presentation and postoperative outcome of cervical neurofibroma type 1. 
Study design:  Retrospective study. 
Place and Duration of Study:  Hayatabad Medical Complex Hospital Peshawar Khyber pakhtoonkhawa from 1st 
February 1999 to 31st July 2011. 
Material and Methods:  A total 41 patients with symptomatic cervical spine neurofibromas who underwent 
surgical decompression and tumor resection were included in this study. Both gender (male and female) and 
patients in the age range of 20 – 70 years were included in this study. These patients were operated through 
posterior approach of the cervical spine and then followed for six months for postoperative outcome .The 
patients’ demographic details and clinical manifestation were entered into a semi structured proforma. Data was 
analyzed through statistical program SPSS version 11. 
Results:  Out of 41 patients, there were 22 (53.6%) males and 19 (46.3%) females. The age of patients ranged 
from 20 to 70 years. In this study the overall mean age was 39.2 years. Majority of patients 19 (46.3%) were in 
the age range of 31 – 40 years. Most common clinical presentation of patient were quadrapresis in 23 (56.1%) 
pain neck 9 (22%) paraparesis 9 (22%) patients. Postoperatively most of the patients recovered from their 
preoperative symptoms. 
Conclusions:  Quadraparesis and pain neck were the common clinical presentation of cervical cord 
neurofibroma type 1. Surgical outcome of cevical neurofibroma type 1 is good. 
Key words:  Cervical neurofibroma type 1, spinal tumor, cervical tumor. 
Abbreviations:  NFI: Neurofibromatosis type 1, NF2: Neurofibromatosis type 1, CNS: Central nervous system. 
 
INTRODUCTION 
The neurofibromatosis are genetic disorders that give 
rise to tumors of the nerve sheath, glia, and meninges. 
Neurofibromatosis type 1 (NF1), previously known 
as von Recklinghausen's or peripheral neurofibroma-
tosis, is characterized by multiple cafe-au-lait spots, 
neurofibromas, axillary freckling, and iris hamarto-
mas. It is an autosomal – dominant disorder affecting 
about one in 4000 individuals. Neurofibromatosis 
type 2 (NF2), previously known as bilateral acoustic 
or central neurofibromatosis, is characterized by mul-
tiple spinal and intracranial tumors, particularly bila-
teral eighth nerve schwannomas (acoustic neuri-
nomas). It is also an autosomal dominant disorder with 
a high penetrance, but it occurs less frequently.
1-3
 
 The gene for neurofibromatosis type 1 is located 
near the centromere on the long arm of chromosome 
17, and the neurofibromatosis type 2 locus is near the 
center of the long arm of chromosome 22.
2
 
 Benign nerve sheath tumors of the spinal nerve 
roots commonly occur sporadically in both types of 
neurofibromatosis. These tumors may not be distin-
guished radiologically or at the time of surgery, but are 
classified pathologically either as neurofibromas or 
schwannomas. Although the precise cell of origin is 
uncertain, both tumors have prominent Schwann cell
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components.
2,4,5
 
 NF1 has a better prognosis with a lower incidence 
of CNS tumors than NF2. However, morbidity and 
mortality rates in NF1 are not negligible.
5,6
 Some of the 
more severe complications are visual loss secondary to 
optic nerve gliomas, spinal cord tumors, scoliosis, vas-
cular lesions, and long – bone abnormalities, which 
sometimes necessitate amputation.
5-7
 
 The purpose of our study was to determine the 
clinical presentation and postoperative outcome of 
cervical neurofibroma type 1. 
 
MATERIAL AND METHODS 
This was a retrospective review of 41 cases involving 
NF-1 patients with symptomatic cervical spine neuro-
fibromas who underwent surgical decompression and 
tumor resection, from 1st February 2001 to 31st July 
2011, at Hayatabad Medical Complex Hospital Pesha-
war Khyber Pakhtoonkhawa. These patients were ope-
rated through posterior approach of the cervical spine 
and then followed for six months for postoperative 
outcome. The patients’ demographic details; clinical 
manifestation and postoperative outcome were entered 
into a semi structured proforma. 
 Data was analyzed through statistical program 
SPSS version 11. All the qualitative variables like gen-
der, quadrapresis, paraparesis, neck pain and urinary 
incontinence were analyzed for percentages and fre-
quencies. Mean + standard deviation was calculated 
for quantitative variable like age. The results were pre-
sented through tables. 
 
RESULTS 
Sex Incidence 
Out of 41 patients, there were 22 (53.6%) males and 
19 (46.3%) females. 
 
Table 1:  Sex Incidence. 
 
Sex No. % 
Male 22 53.6 
Female 19 46.4 
Total 41 100 
 
Age Incidence 
The age of patients ranged from 20 to 70 years. In this 
study the mean age was 39.2 years. Majority of pati-
ents 19 (46.3%) were in the age range of 31 – 40 years 
(Table 2). 
 
Table 2:  Age Distribution. 
 
S. No. Age Group 
Number of 
Patients 
Percentages 
% 
1. 20 – 30   8 19.5 
2. 31 – 40 19 46.3 
3. 41 – 50   7 17.1 
4. 51 – 60   5 12.2 
5. 61 – 70   2 4.9 
 Total    41 100 
 
Clinical Presentation 
 Most common clinical presentation of patient was 
quadrapresis in 23 (56.1%) paraparesis 9 (22%) pain 
neck 9 (22%) patients (Table 3). 
 
Table 3: Clinical Presentation. 
 
S. 
No. 
Clinical 
Presentation 
Number of 
Patients 
Percentages 
(%) 
1. Quadrapresis 23 56.1 
2. Paraparesis   9 22 
3. 
Neck pain radiating 
to upper limb 
  9 22 
4. 
Urinary 
incontinence 
  2 4.9 
 
DISCUSSION 
NF-1 is one of the most common autosomal disorders 
of the central nervous system. The genetic locus of the 
disease is on the long arm of chromosome 17. The 
incidence of central nervous manifestations in NF-1 is 
about 15%. The spinal manifestations of the disease 
are scoliosis, intramedullary tumors (mostly astrocy-
toma), dural dysplasia, meningoceles, and nerve sheath 
tumors. NF1 has been considered be an alternative 
form of neurofibromatosis, showing multiple spinal 
tumors and cafe´-au-lait spot, occuring in several 
members of the same family.
3,5,7,8
 
 These lesions present as slowly progressive mas-
ses that can either compress to the adjacent vital struc-
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tures or interfere with normal physiology. Common 
musculoskeletal impairments associated with neurofib-
romatosis type 1 (NF1) include cervical pain, muscle 
weakness, muscle stiffness, headaches, and postural 
deviations.Cervical cord compression due to spinal 
neurofibroma is a rare but important complication. The 
early diagnosis is important for preventing irreversible 
quadriplegia.
6,7,9
 
 In our study age range was from 20 to 70 years. 
The mean age of presentation was 39.2 years. A study 
was conducted by Taleb FS showed mean age of 42.5 
years.
10
 Leonard JR showed the mean age 29.9 years.
11
 
 In this study most of the patients were male 22 
(53.6%). Ma J also reported male predominance in his 
study.
12
 Scheithauer BW also documented male predo-
minance.
13
 
 Clinical presentation of the patients in our study 
were quadrapresis in 23 (56.1%) patients, paraparesis 
in 9 (22%) patients, neck pain radiating to upper limb 
in 9 (22%) patients and urinary incontinence in 2 
(9.2%) patients. This means that the common clinical 
presentation was quadrapresis. Taleb FS showed the 
same result.
10
 Matti T reported that quadraparesis is 
the common clinical presentation of cervical neurofib-
roma type 1.
14
 
 Postoperatively most of the patient’s 31 (75.6%) 
symptoms improved fully, only nine (21.9%) patients 
having some neurological deficit and one (2.4%) pati-
ent died. Halliday AL showed good recovery post-
operatively.
15
 Matti T showed the good outcome of 
surgery but the mortality was 15.7%, this might be due 
to long follow-up of their study.
14
 Leonard JR docu-
mented that majority of their patients improved post-
operative from their symptoms.
11
 
 
CONCLUSIONS 
Quadraparesis and pain were the common clinical 
presentation of cervical cord neurofibroma type 1. 
Surgical outcome of cervical neurofibroma type 1 is 
good. 
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